Venrock Associates VI, L.P.

Venrock Associates VI, L.P. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in 10x Genomics, Inc. and Adverum Biotechnologies, Inc. The record holds 10 filings, for trades running from 5 August 2014 to 10 December 2020.

Both buying and selling appear: 1 purchase worth €5.1M, against 1 sale worth €72.0M. On balance, insiders were net sellers of €66.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2020: no purchases and 1 sale on the market.

The latest filing, published on 10 December 2020, reports a transaction in 10x Genomics, Inc. The clock since the last published purchase (7 August 2014) now reads 4,477 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.